Fifth Lane Capital »

Crinetics Pharmaceuticals In shares owned by Fifth Lane Capital

Quarter-by-quarter ownership of Crinetics Pharmaceuticals In (CRNX) shares owned by Fifth Lane Capital from 13F filings

Historical chart of Fifth Lane Capital investment in Crinetics Pharmaceuticals In

Tip: Access up to 7 years of quarterly data

All positions including Crinetics Pharmaceuticals In held by Fifth Lane Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crinetics Pharmaceuticals In by Fifth Lane Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $116k 2.5k 46.55

More positions owned by Fifth Lane Capital

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Hologic Call Option (HOLX)
Renatus Tactical Acquis Shs Cl A (RTAC)
Avidity Biosciences Ord (RNA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Cantor Equity Partners Iv Shs Cl A (CEPF)
New Amer Acquisition I Corp Unit 99/99/9999 (NWAX.U)
Amazon Call Option (AMZN)
Cantor Equity Partners Ii Cl A Ord Shs (CEPT)
Ishares Tr 20 Yr Tr Bd Etf Call Option (TLT)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Futurecrest Acquisition Cl A Ord Shs (FCRS)
Btc Dev Corp Ord Shs Cl A (BDCI)
UnitedHealth (UNH)

View all positions for Fifth Lane Capital

Top funds holding Crinetics Pharmaceuticals In

FMR
Vanguard Group
Wellington Management Company
BlackRock
Farallon Capital Management
Driehaus Capital Management
EcoR1 Capital
Henderson Group
Point72 Asset Management
Geode Capital Management
Paradigm Biocapital Advisors
State Street Corporation
Novo A/S
Pictet Asset Management Holding SA
Siren

View all funds holding Crinetics Pharmaceuticals In